Stock Events

Stock Events

Search...

Celltrion Pharm

₩65,300

2

-₩600-0.91% Today

Statistics

Day High

66,500

Day Low

65,100

52W High

133,300

52W Low

57,714.29

Volume

41,261

Avg. Volume

212,658

Mkt Cap

2.85T

P/E Ratio

-

Dividend Yield

-

Dividend

-

Dividends

0%Dividend Yield

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

Earnings

10MayExpected

Q3 2022

Q4 2022

Q1 2023

Q2 2023

Q3 2023

Q4 2023

Q1 2024

211.15

211.48

211.81

212.15

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 068760.KQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

SillaJen, Inc. focuses on biopharmaceuticals, particularly in the therapeutic areas where Celltrion Pharm also operates.

Celltrion Health Care

Cellivery Therapeutics, Inc. is involved in drug delivery technology, which competes in the innovative drug development space similar to Celltrion Pharm.

TissueGene, Inc. is a biotech company focusing on cell and gene therapy, areas that are increasingly competitive with traditional biopharmaceutical approaches.

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea.

Show more...

CEO

Sang-Suk Kim

Country

KR

ISIN

KR7068760008

Listings